Hacker Newsnew | past | comments | ask | show | jobs | submitlogin

how would you incentivize medicine discovery if not for commercial applications?

not like communist countries are well known for groundbreaking new medicine...



It's easy to say that when it doesn't affect you but I had a childhood friend die last year from CF because he couldn't afford the medical treatments. He was using the various "public funding" sites to raise money but in the end it wasn't enough and he died.

I don't know what the solution is as it's a complex issue... but seeing someone young (in their 30s) die from something preventable because they can't afford the drug is perhaps one of the most horrifying and dystopian things I've seen in my life and makes me worried for our future. One presumably where the rich can live 50 years longer than the "poors".


The incentive is saving lives. That's what the researchers are in it for. The research is in large part publicly funded. Pharmaceutical companies are just charging rent on top of the discoveries.

The best argument you can make is that private pharma competes to improve manufacturing processes, but you world also have that in a 100% public system from multiple countries competing/collaborating with each other.


Do you know how much it costs, and how many failed experiments, it takes to develop a drug?


Like I said, that research is already publicly funded, and even if it wasn't it's always worth it to make sure people live longer as a country because more people means more resources to accomplish stuff with.


They can have their cut, but the swell thing to do would be allowing poorer countries to produce it for their domestic use.


Why stop at medicine? Why does anyone get to have enforcable patents in "poor countries", make a profit, etc. etc. Do you also know people can buy the medicine in "poor " countries for free then, and just ship it back to the "non poor"?


What a ridiculously statement. Medicine is never for free. Best case is you have public health insurance, which spreads the cost across the taxpayers, or generic versions that cost less.

The problem you probably mean can be avoided by giving the license to selected companirs only, and gating access to the drug through healthcare providers.




Guidelines | FAQ | Lists | API | Security | Legal | Apply to YC | Contact

Search: